Three abstracts from the ITN’s RAVE study (Rituximab for the Treatment of ANCA-Associated Vasculitis and Microscopic Polyangiitis) led by John Stone, MD (Massachusetts General Hospital) and Ulrich Specks, MD (Mayo Clinic) were presented this week by the RAVE team at the 16th International Vasculitis & ANCA Workshop in Paris, France. These abstracts include:
- “Association of IgM-ANCA with alveolar hemorrhage revisited”
- “Retreatment with rituximab in the RAVE trial”
- “Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis”
Data from the RAVE study’s primary manuscript is also now available on TrialShare, the ITN’s clinical trials research portal. TrialShare provides tools for researchers to both reproduce published analyses and perform novel investigations. Those interested in exploring TrialShare can create an account at ITNTrialShare.org.